Stay updated on Nivolumab for Recurrent IDH-Mutated Gliomas Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Recurrent IDH-Mutated Gliomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Recurrent IDH-Mutated Gliomas Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Publications section updated to clarify that publications are provided voluntarily by the person entering information and relate to the study results. Revision tag updated to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T13:51:18.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The government funding status notice on the page was removed; no changes to the study details, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:21:21.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    No significant changes detected between the two screenshots; core study content, eligibility criteria, and participating locations appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:21:11.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Major update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T07:57:49.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes provided.
    Difference
    0.1%
    Check dated 2025-09-29T04:22:47.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the Back to Top element was removed, with no substantive content changes otherwise.
    Difference
    0.1%
    Check dated 2025-09-14T21:53:03.000Z thumbnail image

Stay in the know with updates to Nivolumab for Recurrent IDH-Mutated Gliomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Recurrent IDH-Mutated Gliomas Clinical Trial page.